{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:10:19Z","timestamp":1784319019945,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymgme.2025.109181","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:13:38Z","timestamp":1750331618000},"page":"109181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The clinical utility of neurofilament light chain for early detection and prediction of disease burden and severity in neuronopathic Gaucher disease"],"prefix":"10.1016","volume":"145","author":[{"given":"Leah","family":"Svarny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arooj","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Goker-Alpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 14","key":"10.1016\/j.ymgme.2025.109181_bb0005","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1242\/jcs.104729","article-title":"Neurofilaments at a glance","volume":"125","author":"Yuan","year":"2012","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109181_bb0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109181_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109181_bb0020","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109181_bb0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ymgme.2025.109181_bb0030","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109181_bb0035","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000422","article-title":"Neurofilament light chain predicts disease activity in relapsing-remitting MS","volume":"5","author":"Varhaug","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109181_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of Plasma Neurofilament Light with Neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109181_bb0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109181_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia","volume":"3","author":"Meeter","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109181_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109181_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.tins.2021.12.004","article-title":"Lysosomal dysfunction in neurodegeneration: emerging concepts and methods","volume":"45","author":"Udayar","year":"2022","journal-title":"Trends Neurosci."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109181_bb0065","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109181_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.11.017","article-title":"Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-pick disease type C1","volume":"25","author":"Agrawal","year":"2023","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109181_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jnc.15891","article-title":"Biomarkers for predicting disease course in Sanfilippo syndrome: an urgent unmet need in childhood-onset dementia","volume":"166","author":"Winner","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2025.109181_bb0080","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fnins.2020.00579","article-title":"Neurofilament-light chain as biomarker of neurodegenerative and rare diseases with high translational value","volume":"14","author":"Loeffler","year":"2020","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109181_bb0085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jns.12279","article-title":"Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies","volume":"23","author":"Mariotto","year":"2018","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109181_bb0090","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109181_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13023-023-02623-7","article-title":"Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review","volume":"18","author":"Giuffrida","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109181_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043945","article-title":"Contribution of Glucosylsphingosine (Lyso-Gb1) to treatment decisions in patients with Gaucher disease","volume":"24","author":"Dinur","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109181_bb0105","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jimd.12235","article-title":"The definition of neuronopathic Gaucher disease","volume":"43","author":"Schiffmann","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109181_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejim.2013.09.006","article-title":"Gaucher disease: a diagnostic challenge for internists","volume":"25","author":"Cassinerio","year":"2014","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109181_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2021.01.002","article-title":"Diagnosing neuronopathic Gaucher disease: new considerations and challenges in assigning Gaucher phenotypes","volume":"132","author":"Daykin","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109181_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109181_bb0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2022.03.001","article-title":"The diagnosis and management of Gaucher disease in pediatric patients: where do we go from here?","volume":"136","author":"Weinreb","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"447","key":"10.1016\/j.ymgme.2025.109181_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1651-2227.2005.tb02111.x","article-title":"Clinical evaluation of biomarkers in Gaucher disease","volume":"94","author":"Deegan","year":"2005","journal-title":"Acta Paediatr. Suppl."},{"issue":"447","key":"10.1016\/j.ymgme.2025.109181_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1651-2227.2005.tb02110.x","article-title":"Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases","volume":"94","author":"Aerts","year":"2005","journal-title":"Acta Paediatr. Suppl."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109181_bb0140","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/acn3.51676","article-title":"Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface","volume":"9","author":"Vermunt","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymgme.2025.109181_bb0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cca.2022.08.017","article-title":"Plasma neurofilament light chain (NfL) reference interval determination in an age-stratified cognitively unimpaired cohort","volume":"535","author":"Bornhorst","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109181_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117229","article-title":"The relationship between neurofilament light chain and cognition in neurological disorders: a scoping review","volume":"420","author":"Ramani","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109181_bb0155","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jimd.12749","article-title":"Neuronopathic Gaucher disease: rare in the west, common in the east","volume":"47","author":"Goker-Alpan","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109181_bb0160","first-page":"11","article-title":"Neuroinflammation in neuronopathic Gaucher disease: role of microglia and NK cells, biomarkers, and response to substrate reduction therapy","author":"Boddupalli","year":"2022","journal-title":"Elife"},{"issue":"6048","key":"10.1016\/j.ymgme.2025.109181_bb0165","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1126\/science.1202529","article-title":"Synaptic pruning by microglia is necessary for normal brain development","volume":"333","author":"Paolicelli","year":"2011","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109181_bb0170","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109181_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s13023-022-02549-6","article-title":"An observational study to investigate the relationship between plasma glucosylsphingosine (lyso-Gb1) concentration and treatment outcomes of patients with Gaucher disease in Japan","volume":"17","author":"Ida","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109181_bb0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/01.WNL.0000130191.31669.48","article-title":"Deterioration of the auditory brainstem response in children with type 3 Gaucher disease","volume":"63","author":"Campbell","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109181_bb0185","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1093\/brain\/awac394","article-title":"Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal","volume":"146","author":"Benatar","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109181_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac310","article-title":"The role of neurofilament light in genetic frontotemporal lobar degeneration","volume":"5","author":"Zetterberg","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.ymgme.2025.109181_bb0195","doi-asserted-by":"crossref","first-page":"1269406","DOI":"10.3389\/fneur.2023.1269406","article-title":"Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioi","volume":"14","author":"Flotats-Bastardas","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2025.109181_bb0200","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbi.2024.02.002","article-title":"Systemic inflammation relates to neuroaxonal damage associated with long-term cognitive dysfunction in COVID-19 patients","volume":"117","author":"Duindam","year":"2024","journal-title":"Brain Behav. Immun."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:55:34Z","timestamp":1764834934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225001726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1096719225001726"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109181","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical utility of neurofilament light chain for early detection and prediction of disease burden and severity in neuronopathic Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109181"}}